We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
-18.06%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$114M
AUM Growth
-$45.4M
(-29%)
Cap. Flow
-$5.62M
Cap. Flow
% of AUM
-4.95%
Top 10 Holdings %
Top 10 Hldgs %
71.92%
Holding
113
New
28
Increased
8
Reduced
15
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$4.74M |
| 2 |
Old Dominion Freight Line
ODFL
|
+$1.77M |
| 3 |
Broadridge
BR
|
+$990K |
| 4 |
Fastenal
FAST
|
+$987K |
| 5 |
Amazon
AMZN
|
+$956K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$5.63M |
| 2 |
Broadcom
AVGO
|
+$1.69M |
| 3 |
Hasbro
HAS
|
+$1.55M |
| 4 |
HF Sinclair
DINO
|
+$1.14M |
| 5 |
Iron Mountain
IRM
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.4% |
| 2 | Industrials | 6.13% |
| 3 | Financials | 4.38% |
| 4 | Consumer Staples | 3.54% |
| 5 | Technology | 2.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axsome Therapeutics
AXSM
$12.4B
| $37.3M | 32.87% |
1,132,645
+121,700
| +12% | +$4.74M |
|
|
RNAM
2
DELISTED
Avidity Biosciences
RNAM
| $22.4M | 19.68% |
907,567
-259,180
| -22% | -$5.63M |
|
3
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $9.88M | 8.7% |
108,084
| – | – |
|
|
SPPI
4
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.61M | 3.18% |
1,656,815
+7,500
| +0.5% | +$20.5K |
|
|
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
| $2.63M | 2.31% |
58,602
| – | – |
|
|
6
Old Dominion Freight Line
ODFL
$48.5B
| $1.83M | 1.61% |
+12,790
| New | +$1.77M |
|
7
Waste Management
WM
$95.9B
| $1.24M | 1.09% |
8,290
+4,390
| +113% | +$657K |
|
|
8
Broadridge
BR
$17.2B
| $969K | 0.85% |
+5,812
| New | +$990K |
|
|
9
Fastenal
FAST
$54B
| $938K | 0.83% |
+36,368
| New | +$987K |
|
|
10
Amazon
AMZN
$2.5T
| $910K | 0.8% |
+5,540
| New | +$956K |
|
11
AbbVie
ABBV
$458B
| $892K | 0.79% |
8,270
+2,101
| +34% | +$240K |
|
12
Sanofi
SNY
$104B
| $868K | 0.76% |
+18,012
| New | +$916K |
|
13
Coca-Cola
KO
$354B
| $817K | 0.72% |
15,566
+9,066
| +139% | +$505K |
|
14
AutoZone
AZO
$48.3B
| $788K | 0.69% |
+464
| New | +$744K |
|
15
Quest Diagnostics
DGX
$25.1B
| $762K | 0.67% |
+5,243
| New | +$767K |
|
16
Yum! Brands
YUM
$41B
| $736K | 0.65% |
+6,015
| New | +$763K |
|
17
US Bancorp
USB
$99.6B
| $722K | 0.64% |
+12,146
| New | +$692K |
|
18
Nucor
NUE
$56.4B
| $711K | 0.63% |
+7,214
| New | +$767K |
|
19
Alphabet (Google) Class C
GOOG
$3.9T
| $706K | 0.62% |
5,300
-1,800
| -25% | -$248K |
|
20
Duke Energy
DUK
$102B
| $697K | 0.61% |
7,141
+1,641
| +30% | +$170K |
|
21
Alliant Energy
LNT
$19.4B
| $695K | 0.61% |
+12,409
| New | +$733K |
|
22
Archer Daniels Midland
ADM
$41.4B
| $685K | 0.6% |
+11,419
| New | +$685K |
|
23
Bank of America
BAC
$435B
| $680K | 0.6% |
16,012
-501
| -3% | -$20.2K |
|
24
Elevance Health
ELV
$81.9B
| $676K | 0.6% |
+1,813
| New | +$689K |
|
25
J.M. Smucker
SJM
$12.6B
| $641K | 0.56% |
+5,340
| New | +$679K |
|
Similar funds
WM
LWA
CPI
WAL
NLWP
ICMARC
RAM
MHFA
Alethea Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Alethea Capital Management held 113 positions worth $114M, down 29% from $159M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Alethea Capital Management withdrew a net $5.62M in Q3 2021, closing 32 positions and reducing 15 holdings. Its most notable exit was Broadcom, an estimated $1.69M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 70% a quarter earlier, followed by Industrials and Financials.
Against the trend, Alethea Capital Management opened a new position in Old Dominion Freight Line worth $1.83M.
- Alethea Capital Management's largest Q3 2021 buy was Old Dominion Freight Line: 12,790 shares worth $1.83M.
- Alethea Capital Management added most to Axsome Therapeutics in Q3 2021, an estimated $4.74M increase.
- Alethea Capital Management's biggest Q3 2021 reduction was Avidity Biosciences, cutting an estimated $5.63M.
- Alethea Capital Management fully exited Broadcom in Q3 2021, selling an estimated $1.69M.
- Alethea Capital Management's ten largest holdings make up 72% of its $114M portfolio in Q3 2021.
- Alethea Capital Management opened 28 new positions and closed 32 in Q3 2021.
- Alethea Capital Management's portfolio value fell 29% quarter-over-quarter to $114M.
Based on Alethea Capital Management's 13F filing for Q3 2021, filed 27 Oct 2021.